Trifluoromethylphenyl as P2 for ketoamide-based cathepsin S inhibitors

Jiaqiang Cai1, John Robinson, Simone Belshaw

  • 1Merck Research Laboratories, MSD, Newhouse, Lanarkshire, United Kingdom. jiaqiang.cai@merck.com